Assessing the Right Heart Remodeling After Transcatheter Tricuspid Edge-to-edge Repair - Trial NCT06309524
Access comprehensive clinical trial information for NCT06309524 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Auxologico Italiano and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 17 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Istituto Auxologico Italiano
Timeline & Enrollment
N/A
Feb 15, 2023
Jan 01, 2025
Primary Outcome
Inverse remodeling of right heart chambers,Heart failure hospitalization,Death
Summary
In the recent years, secondary tricuspid regurgitation (STR) has gained interest due to its
 high prevalence and impact on outcomes. Transcatheter tricuspid valve replacement or repair
 represents novel and less invasive alternatives to surgery and has shown early promising
 results. Treatment options mimic surgical techniques such as leaflet approximation, direct
 annuloplasty, and heterotopic caval valve implantation, as well as not yet commercially
 available transcatheter TV replacement systems using orthotopic valve implantation. (5) Among
 leaflet approximation techniques, the Tricuspid transcatheter edge-to-edge repair (T-TEER)
 using the TriClipโข (Abbott Vascular, Santa Clara, CA, USA) or leaflet approximation with the
 PASCAL systems (Edwards Lifesciences, Irvine, CA, USA) are approved in Europe for minimally
 invasive TV repair.The purposes of the present study are: i. to use 3DE and CCT to evaluate
 the effect of T-TEER on the geometry and function of the right heart chambers in patients
 with STR; ii. to identify the predictors of procedural success potentially related to
 features of both right chambers geometry and TR jet; iii. to compare the accuracy of 3DE
 assessment of the right ventricle, the right atrium, and the tricuspid annulus, with the same
 parameters obtained by CCT, in the setting of T-TEER; and iv. to assess patients' outcome.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06309524
Device Trial

